What Are the Stages of Mesothelioma?

Understanding the TNM Staging System

Mesothelioma staging uses the TNM system developed by the International Association for the Study of Lung Cancer (IASLC) and adopted by the American Joint Committee on Cancer (AJCC). The system evaluates three factors: the extent of the primary Tumor, whether cancer has spread to nearby lymph Nodes, and whether distant Metastasis has occurred.

It is important to note that the formal TNM staging system applies only to pleural mesothelioma. Peritoneal mesothelioma and other rarer forms do not have an established staging system, though physicians use alternative classification methods to assess disease extent and guide treatment decisions.

Staging is determined through a combination of imaging studies, biopsy results, and sometimes surgical findings. Accurate staging is essential because it directly determines which treatments are appropriate and provides a framework for discussing prognosis with patients and their families.

Stage 1: Localized Disease

Stage 1 mesothelioma is the earliest and most treatable stage. The cancer is confined to the pleural lining on one side of the chest and has not spread to lymph nodes or distant sites. Stage 1 is divided into 1A (tumor limited to one layer of the pleura) and 1B (tumor involves both the parietal and visceral pleura).

Patients diagnosed at Stage 1 have the widest range of treatment options, including potentially curative surgery such as pleurectomy/decortication (P/D) or extrapleural pneumonectomy (EPP), combined with chemotherapy and radiation therapy.

Stage 2: Early Spread

Stage 2 mesothelioma indicates that the cancer has grown beyond the pleural lining into nearby structures such as the diaphragm, lung tissue, or chest wall on one side. Lymph nodes on the same side of the chest may or may not be involved. Surgical options may still be available, though the extent of resection and the overall treatment approach become more complex.

The transition from Stage 1 to Stage 2 represents a meaningful change in the disease's behavior, as tumor invasion into surrounding tissues makes complete surgical removal more challenging. However, patients with Stage 2 disease who are otherwise in good health may still benefit from multimodal treatment approaches.

Stage 3: Advanced Local Spread

Stage 3 mesothelioma indicates more extensive local or regional spread. The cancer may have invaded the chest wall, mediastinum (the space between the lungs), heart lining (pericardium), or other structures. Lymph node involvement on the same side of the chest is typical at this stage. Surgery may still be considered in some Stage 3 cases, but systemic treatments — chemotherapy and immunotherapy — play a larger role.

Stage 3 is one of the most common stages at diagnosis because mesothelioma symptoms often do not become pronounced enough to prompt medical evaluation until the disease has progressed significantly.

Stage 4: Distant Metastasis

Stage 4 mesothelioma means the cancer has spread to the opposite side of the chest, distant lymph nodes, or organs such as the liver, brain, bones, or adrenal glands. At this stage, treatment focuses on managing symptoms, maintaining quality of life, and extending survival through systemic therapies including chemotherapy, immunotherapy, and palliative care.

While Stage 4 mesothelioma is not considered curable, advances in immunotherapy and targeted treatments have improved outcomes for some patients. Clinical trials may also offer access to emerging therapies not yet widely available.

Staging and Legal Considerations

The stage at diagnosis can affect the urgency and structure of a mesothelioma legal claim. Patients with advanced-stage disease may need expedited legal proceedings, including depositions by written questions or video testimony, to preserve their testimony. Regardless of stage, every mesothelioma patient has the right to explore compensation options for their asbestos exposure. An experienced mesothelioma attorney can help ensure that the legal process accommodates the patient's medical situation.